pyruvaldehyde has been researched along with mangiferin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, HP; Liu, YW; Lu, Q; Wang, JY; Wei, YQ; Yang, QQ; Yin, JL; Yin, XX; Zhu, X | 1 |
1 other study(ies) available for pyruvaldehyde and mangiferin
Article | Year |
---|---|
Suppression of methylglyoxal hyperactivity by mangiferin can prevent diabetes-associated cognitive decline in rats.
Topics: Animals; Behavior, Animal; Cognition Disorders; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Glutathione; Glycation End Products, Advanced; Hippocampus; Inflammation; Male; Malondialdehyde; Maze Learning; Oxidative Stress; Pyruvaldehyde; Rats; Rats, Sprague-Dawley; Streptozocin; Superoxide Dismutase; Xanthones | 2013 |